Novel Class Of Antimicrobials Kills Multidrug Resistant-Tuberculosis

News   May 21, 2015

 
Novel Class Of Antimicrobials Kills Multidrug Resistant-Tuberculosis
 
 
 

RELATED ARTICLES

Could New Treatment Strategy Overcome Drug Resistance in Testicular Cancer?

News

In a new study, scientists show that a targeted drug blocking the action of a cancer-driving protein can kill testicular cancer cells and, alongside chemotherapy, could reverse drug resistance.

READ MORE

New Rare Antibody Isolation Strategy

News

A strategy for rapidly isolating rare, naturally occurring antibodies is reported this week. The strategy could aid in developing biological therapeutics and vaccines in the future.

READ MORE

Potential Drug Target: Cryo-EM Uncovers Protein Modifying Complex

News

Scientists have revealed the atomic-level structure of a molecular complex responsible for modifying proteins, possibly paving the way for the development of new medications for cancer and a host of other diseases.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE